Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hydrofera Blue is an antibacterial wound dressing medical device composed of a polyvinyl alcohol (PVA) or polyurethane foam impregnated with two organic pigments: methylene blue and gentian violet. These agents provide broad-spectrum antimicrobial and antifungal protection against pathogens such as MRSA, VRE, and *Candida*. The dressing operates through a capillary wicking action that actively pulls exudate, debris, and bacteria away from the wound bed into the foam, maintaining a moist environment conducive to healing. It is indicated for a wide range of wounds, including pressure ulcers, diabetic foot ulcers, venous stasis ulcers, arterial ulcers, superficial burns, and post-surgical incisions. Originally cleared by the FDA in 2003, it is manufactured by Hollister Wound Care.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Hydrofera Blue.